{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:25:05Z","timestamp":1794619505700,"version":"4.9.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["U24HL143217"],"award-info":[{"award-number":["U24HL143217"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["UH3HL143192"],"award-info":[{"award-number":["UH3HL143192"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ahj.2026.107542","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:19:11Z","timestamp":1784179151000},"page":"107542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design, rationale, and baseline patient characteristics for the Sickle Cell Disease and CardiovAscular Risk-Red cell Exchange (SCD-CARRE) trial"],"prefix":"10.1016","volume":"301","author":[{"given":"Marnie","family":"Bertolet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell J.","family":"Triulzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Campbell-Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor R.","family":"Gordeuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon M.","family":"Herbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Jonassaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flordeliza","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nydia","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Gladwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2030-7873","authenticated-orcid":false,"given":"Maria Mori","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2026.107542_bib0001","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ahj.2026.107542_bib0002","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/S0140-6736(16)00647-4","article-title":"Cardiovascular complications and risk of death in sickle-cell disease","volume":"387","author":"Gladwin","year":"2016","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ahj.2026.107542_bib0003","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/bjh.13447","article-title":"Estimated pulmonary artery systolic pressure and sickle cell disease: a meta-analysis and systematic review","volume":"170","author":"Caughey","year":"2015","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.ahj.2026.107542_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099489","article-title":"Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom","volume":"9","author":"Gladwin","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ahj.2026.107542_bib0005","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary hypertension as a risk factor for death in patients with sickle cell disease","volume":"350","author":"Gladwin","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107542_bib0006","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1164\/rccm.201401-0065ST","article-title":"An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease","volume":"189","author":"Klings","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ahj.2026.107542_bib0007","doi-asserted-by":"crossref","first-page":"E312","DOI":"10.1002\/ajh.25624","article-title":"Validation of a composite vascular high-risk profile for adult patients with sickle cell disease","volume":"94","author":"Nouraie","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ahj.2026.107542_bib0008","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1681\/ASN.2002010084","article-title":"Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure","volume":"17","author":"Guasch","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ahj.2026.107542_bib0009","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bjh.12690","article-title":"Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia","volume":"164","author":"Saraf","year":"2014","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.ahj.2026.107542_bib0010","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.md.0000189089.45003.52","article-title":"Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients","volume":"84","author":"Powars","year":"2005","journal-title":"Medicine"},{"key":"10.1016\/j.ahj.2026.107542_bib0011","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107542_bib0012","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00277-011-1327-8","article-title":"New insights on pathophysiology, clinical manifestations, diagnosis, and treatment of sickle cell nephropathy","volume":"90","author":"da Silva","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ahj.2026.107542_bib0013","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1111\/trf.13800","article-title":"Erythrocytapheresis for chronic transfusion therapy in sickle cell disease: survey of current practices and review of the literature","volume":"56","author":"Kelly","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.ahj.2026.107542_bib0014","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00272-2018","article-title":"Chronic blood exchange transfusions in the management of pre-capillary pulmonary hypertension complicating sickle cell disease","volume":"52","author":"Turpin","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ahj.2026.107542_bib0015","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1182\/bloodadvances.2019000916","article-title":"American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease","volume":"3","author":"Liem","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.ahj.2026.107542_bib0017","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/bloodadvances.2019001143","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support","volume":"4","author":"Chou","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.ahj.2026.107542_bib0018","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1164\/rccm.201404-0733LE","article-title":"Reply: practice guideline for pulmonary hypertension in sickle cell: direct evidence needed before universal adoption","volume":"190","author":"Klings","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ahj.2026.107542_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099489","article-title":"Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom","volume":"9","author":"Gladwin","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ahj.2026.107542_bib0020","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/rccm.200710-1606OC","article-title":"Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease","volume":"177","author":"Mekontso Dessap","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ahj.2026.107542_bib0021","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/ajh.25202","article-title":"Clustering of end-organ disease and earlier mortality in adults with sickle cell disease: a retrospective-prospective cohort study","volume":"93","author":"Chaturvedi","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ahj.2026.107542_bib0022","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12955-017-0661-5","article-title":"Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS\u00ae to ASCQ-Me\u2120","volume":"15","author":"Keller","year":"2017","journal-title":"Health Qual Life Outc"},{"key":"10.1016\/j.ahj.2026.107542_bib0023","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/AJP.0000000000000054","article-title":"Adult sickle cell quality-of-life measurement information system (ASCQ-Me): conceptual model based on review of the literature and formative research","volume":"30","author":"Treadwell","year":"2014","journal-title":"Clin J Pain"},{"key":"10.1016\/j.ahj.2026.107542_bib0024","doi-asserted-by":"crossref","DOI":"10.2196\/10056","article-title":"Abstract Animations for the communication and assessment of pain in adults: cross-sectional feasibility study","volume":"20","author":"Jonassaint","year":"2018","journal-title":"J Med Internet Res"},{"issue":"5","key":"10.1016\/j.ahj.2026.107542_bib0025","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107542_bib0026","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.111.032920","article-title":"Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom","volume":"124","author":"Sachdev","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107542_bib0027","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jacc.2006.09.038","article-title":"Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease","volume":"49","author":"Sachdev","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107542_bib0028","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1001\/jama.2022.21506","article-title":"Adjustment for baseline characteristics in randomized clinical trials","volume":"328","author":"Holmberg","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2026.107542_bib0029","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tmrv.2006.11.003","article-title":"Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines","volume":"21","author":"Josephson","year":"2007","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.ahj.2026.107542_bib0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1182\/bloodadvances.2020003197","article-title":"Longitudinal effect of disease-modifying therapy on tricuspid regurgitant velocity in children with sickle cell anemia","volume":"5","author":"Rai","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.ahj.2026.107542_bib0031","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1182\/bloodadvances.2024013216","article-title":"Evaluation of hemoglobin S percent threshold to prevent severe pain events: a secondary analysis of the SIT trial","volume":"8","author":"Mejias","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.ahj.2026.107542_bib0032","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.rmed.2006.01.001","article-title":"Reference values for the 6-min walk test in healthy subjects 20-50 years old","volume":"100","author":"Chetta","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.ahj.2026.107542_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2025.106026","article-title":"Normative reference values for the six-minute walk test in older adults: a systematic review and meta-analysis","volume":"140","author":"Otadi","year":"2026","journal-title":"Arch Gerontol Geriatr"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870326002048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870326002048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:23:15Z","timestamp":1790709795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870326002048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":32,"alternative-id":["S0002870326002048"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107542","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, rationale, and baseline patient characteristics for the Sickle Cell Disease and CardiovAscular Risk-Red cell Exchange (SCD-CARRE) trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107542"}}